SQOR can shape tumor fate by tuning CoQ10H2 and redox defense, yet its direction depends on metabolic needs and immune context—pro-growth in hypoxic/high-demand tumors but suppressive in immune-active tumors. This evidence concerns the gene SQOR and neoplasm.